BIOMAT Database Logo BIOMAT Database Logo

[Molecular forms of PSA and differentiating between benign hypertrophy,carcinoma, and disseminated prostatic carcinoma. Correlation between two determination technics]. 1999

C Sáez Lavilla, and A Guallar Labrador, and J Castrillo Rubio, and C A Allepuz Losa, and T Baringo Fuentes, and A Ascaso Bandrés, and A L Navarro Izquierdo, and L A Rioja Sanz
Servicio de Medicina Nuclear, Hospital Miguel Servet, Zaragoza, España.

OBJECTIVE To determine the correlation between two methods of measurement of total PSA (PSA-T) and free PSA (PSA-F) and the utility of the PSA-F/PSA-T ratio in patients with PSA-T between 4 and 10 ng/ml suspected as having prostate cancer. METHODS Determinations of both PSA-T and PSA-F were performed using two different techniques in 91 patients suspected as having prostate cancer. Diagnosis was made on the findings of biopsy and the complementary tests. RESULTS The following correlation was found for the two techniques: R = 0.99 and p < 0.05 for PSA-T, and R = 0.85 and p < 0.05 for PSA-F. For PSA-T values of 4-10 ng/ml and PSA-F greater than 25%, we found two patients with prostate cancer. For a PSA-F/PSA-T ratio less than 9%, all cases had prostate cancer. Three cases with bone metastasis had PSA-T values less than 10 ng/ml. CONCLUSIONS A PSA-F/PSA-T ratio greater than 25% does not exclude malignancy in patients with a total PSA of 4-10 ng/ml; values less than 9% correspond to prostate cancer. Bone metastasis was found with both methods in patients with total PSA values less than 10 ng/ml.

UI MeSH Term Description Entries
D008297 Male Males
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D017430 Prostate-Specific Antigen A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. Kallikrein hK3,gamma-Seminoprotein,hK3 Kallikrein,Prostate Specific Antigen,Semenogelase,Seminin,Kallikrein, hK3,gamma Seminoprotein

Related Publications

C Sáez Lavilla, and A Guallar Labrador, and J Castrillo Rubio, and C A Allepuz Losa, and T Baringo Fuentes, and A Ascaso Bandrés, and A L Navarro Izquierdo, and L A Rioja Sanz
[Usefulness of PSA density (PSAD) in the differential diagnosis between prostatic adenocarcinoma and benign ++ prostatic hypertrophy].
September 1994, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica,
C Sáez Lavilla, and A Guallar Labrador, and J Castrillo Rubio, and C A Allepuz Losa, and T Baringo Fuentes, and A Ascaso Bandrés, and A L Navarro Izquierdo, and L A Rioja Sanz
Usefulness of PSA density and PSA excess in the differential diagnosis between prostate cancer and benign prostatic hypertrophy.
January 1996, The International journal of biological markers,
C Sáez Lavilla, and A Guallar Labrador, and J Castrillo Rubio, and C A Allepuz Losa, and T Baringo Fuentes, and A Ascaso Bandrés, and A L Navarro Izquierdo, and L A Rioja Sanz
[Usefulness of free/total PSA ratio and PSA density in distinguishing benign prostatic hypertrophy from prostatic cancer].
October 2001, Actas urologicas espanolas,
C Sáez Lavilla, and A Guallar Labrador, and J Castrillo Rubio, and C A Allepuz Losa, and T Baringo Fuentes, and A Ascaso Bandrés, and A L Navarro Izquierdo, and L A Rioja Sanz
[The relationship of PSA to age and prostatic volume in patients with benign prostatic hypertrophy].
March 1995, Actas urologicas espanolas,
C Sáez Lavilla, and A Guallar Labrador, and J Castrillo Rubio, and C A Allepuz Losa, and T Baringo Fuentes, and A Ascaso Bandrés, and A L Navarro Izquierdo, and L A Rioja Sanz
[PSA and benign prostatic hyperplasia].
December 2004, Annales d'urologie,
C Sáez Lavilla, and A Guallar Labrador, and J Castrillo Rubio, and C A Allepuz Losa, and T Baringo Fuentes, and A Ascaso Bandrés, and A L Navarro Izquierdo, and L A Rioja Sanz
[Prostatic carcinoma and benign hypertrophy. Magnetic resonance aspects].
January 1986, Acta urologica Belgica,
C Sáez Lavilla, and A Guallar Labrador, and J Castrillo Rubio, and C A Allepuz Losa, and T Baringo Fuentes, and A Ascaso Bandrés, and A L Navarro Izquierdo, and L A Rioja Sanz
Texture analysis--a new method of differentiating prostatic carcinoma from prostatic hypertrophy.
January 1988, Urological research,
C Sáez Lavilla, and A Guallar Labrador, and J Castrillo Rubio, and C A Allepuz Losa, and T Baringo Fuentes, and A Ascaso Bandrés, and A L Navarro Izquierdo, and L A Rioja Sanz
[Benign prostatic hypertrophy and the benign prostatic syndrome].
January 2008, Pharmazie in unserer Zeit,
C Sáez Lavilla, and A Guallar Labrador, and J Castrillo Rubio, and C A Allepuz Losa, and T Baringo Fuentes, and A Ascaso Bandrés, and A L Navarro Izquierdo, and L A Rioja Sanz
[PSA values before and after finasteride treatment in patients with benign prostatic hypertrophy].
February 1995, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica,
C Sáez Lavilla, and A Guallar Labrador, and J Castrillo Rubio, and C A Allepuz Losa, and T Baringo Fuentes, and A Ascaso Bandrés, and A L Navarro Izquierdo, and L A Rioja Sanz
Correlation between angiotensin-converting enzyme activity and histologic patterns in benign prostatic hypertrophy tissue.
February 1982, The Journal of urology,
Copied contents to your clipboard!